02.05.2007 15:00:00
|
New Vaccine Taking Wing to Rid Beak and Feather Disease in Companion Birds
University of Georgia scientists are finalizing development of a new
vaccine that could effectively eliminate in companion bird populations a
debilitating and often fatal viral disease called psittacine beak and
feather disease.
The virus has decimated some free-ranging populations of cockatoos and
has historically been a problem for companion-bird lovers from around
the globe. The virus is not contagious to humans or other pets.
According to the American Pet Products Manufacturers Association, more
than 16 million birds live as companions in American households.
More than 40 species of free-ranging and companion birds, most notably
lovebirds, cockatoos, eclectus parrots and African gray parrots, are
readily susceptible to infection. The virus also can infect and cause
disease in other psittacine birds such as budgerigars (budgies), Indian
ringneck parakeets, lories, lorikeets and occasionally macaws and Amazon
parrots.
The disease, which is transmissible from bird to bird and is not
treatable, attacks a bird’s ability to
properly grow feathers, beaks and claws. Feathers deteriorate and fall
off and beaks and claws can break and crumble away or grow soft, making
the bird susceptible to life-threatening secondary infections. The
disease can be most fatal to young birds while more mature birds that
have been exposed to the virus can build up immunities and be protected
through their lifetime.
After classifying the cause of this disease as a new family of viruses
(the circoviruses) in the late 1980s, scientists from The University of
Georgia College of Veterinary Medicine developed a state-of-the-art
diagnostic test and then turned their attention to developing a vaccine
to prevent healthy birds from becoming infected in the first place. "PetSmart
provided much needed financial support and other resources to expedite
and finalize the production of the vaccine candidate,”
said Branson Ritchie, a doctor of veterinary medicine, Ph.D., and
distinguished research professor.
The company donated $300,000 in an undesignated gift to the College of
Veterinary Medicine to be used for research.
"It’s one of the
most prevalent and debilitating diseases to attack companion and
free-ranging birds,” said Dr. Nick Saint-Erne,
PetSmart’s quality assurance veterinarian. "Because
it affects such a broad spectrum of species, a vaccine will have a
positive, far-reaching effect on the health and quality of life of birds
everywhere,” he said.
Researchers have long sought to unlock the keys to a vaccine, made
difficult because the virus "was so difficult
to kill,” Ritchie said. Initially,
researchers derived a vaccine by purifying the virus from the tissues of
infected birds. While the methodology worked and experiments using this
vaccine proved that vaccinated birds could develop protective immunity,
the tissue-derived vaccine was far too dangerous and impractical for
widespread use, he said.
The breakthrough came when Ritchie’s team was
able to express portions of the viral proteins –
a necessary building block for the vaccine –
in a repeatable, easily qualified laboratory system.
With laboratory work now successfully completed, the University of
Georgia Research Foundation has begun the licensing and registration
process for the vaccine. That process could be completed by the middle
of 2008, and includes manufacturing a vaccine and testing it on birds
that are hatched in captivity and destined for sale.
"We’ll be very
happy when it’s in a bottle and on a shelf,”
Ritchie said, referring to successful registration and commercial
availability of the vaccine to bird breeders, medical care providers,
pet stores and bird owners. "The vaccine will
not only greatly improve the ability of companion birds to live long and
healthy lives, it might also have applications in the field to help
protect endangered species of susceptible birds,”
he said.
About PetSmart
PetSmart, Inc. (NASDAQ: PETM) is the largest specialty pet retailer of
services and solutions for the lifetime needs of pets. The company
operates more than 908 pet stores in the United States and Canada, a
growing number of in-store PetsHotel cat and dog boarding facilities,
and is a leading online provider of pet supplies and pet care
information (www.petsmart.com).
PetSmart provides a broad range of competitively priced pet food and pet
products; and offers complete pet training, pet grooming, pet boarding,
doggie day camp and pet adoption services.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu PETsMART Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu PETsMART Inc.mehr Analysen
Indizes in diesem Artikel
NASDAQ Comp. | 19 627,44 | -0,28% | |
NASDAQ 100 | 21 478,05 | -0,14% |